# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA683161 | F | Compound was evaluated for inhibitory activity against H69 human lung cancer cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
2. | ALA686760 | F | Compound was evaluated for inhibitory activity against H 358 human lung cancer cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
3. | ALA686761 | F | Compound was evaluated for inhibitory activity against H 460 human lung cancer cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
4. | ALA695426 | F | Concentration yielding an amount of cellular protein at the end of the incubation that is the same as at the beginning of the incubation in brain tumor sub panel | Homo sapiens | 22 | organism-based format | Scientific Literature | ||
5. | ALA695427 | F | Concentration yielding an amount of cellular protein at the end of the incubation that is the same as at the beginning of the incubation in full panel | Homo sapiens | 22 | organism-based format | Scientific Literature | ||
6. | ALA712036 | F | Antitumor activity against L1210 leukemia cells expressed as dose concentration that reduces number of cells by 50% after 48 hrs exposure to drug. | Mus musculus | 4 | cell-based format | Scientific Literature | ||
7. | ALA703475 | F | Antitumor efficiency against L1210 leukemia cells expressed as % increase in life span (ILS) 24 hrs after ip grafting (10e5 cells) | Mus musculus | 2 | organism-based format | Scientific Literature | ||
8. | ALA727368 | F | Cytotoxicity against L1210 leukemia cells administered through intraperitoneal route in mice | Mus musculus | 2 | organism-based format | Scientific Literature | ||
9. | ALA752387 | F | Compound was evaluated for inhibitory activity against N 417 human lung cancer cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
10. | ALA850398 | F | Ratio between brain tumor full panel [A] and sub panel [B] | 22 | assay format | Scientific Literature | |||
11. | ALA838912 | F | TGI correlation coefficient value of the compound | Homo sapiens | 22 | organism-based format | Scientific Literature | ||
12. | ALA3292168 | F | Antimalarial activity against Plasmodium berghei infected in mouse assessed as suppression of parasitemia at 50 mg/kg, po after 5 to 7 days | Plasmodium berghei | 1 | organism-based format | Scientific Literature | ||
13. | ALA3292169 | F | Antimalarial activity against Plasmodium berghei infected in mouse assessed as suppression of parasitemia at 10 mg/kg, po after 5 to 7 days | Plasmodium berghei | 1 | organism-based format | Scientific Literature | ||
14. | ALA3292171 | F | Antiplasmodial activity against multi-drug resistant Plasmodium falciparum K1 in human erythrocytes assessed as growth inhibition after 48 hrs by optical microscopy | Plasmodium falciparum | 7 | organism-based format | Scientific Literature | ||
15. | ALA3292172 | F | Antiplasmodial activity against drug susceptible Plasmodium falciparum 3D7 NF54 isolate in human erythrocytes assessed as growth inhibition after 48 hrs by optical microscopy | Plasmodium falciparum | 7 | organism-based format | Scientific Literature | ||
16. | ALA3292174 | A | Cytotoxicity against mouse macrophages after 18 hrs by MTT assay | Mus musculus | 5 | cell-based format | Scientific Literature | ||
17. | ALA3292175 | U | Selectivity index, ratio of IC50 for mouse macrophages to IC50 for Plasmodium falciparum | 2 | assay format | Scientific Literature |